jump to navigation

Accelerator Loan Pays Off with Pluromed’s FDA Approval of Medical Device Backstop™ 09/28/2009

Posted by Morse, Barnes-Brown Pendleton in Client News.
trackback

Pluromed, Inc.MBBP client Pluromed, Inc. has received FDA approval for BackStop™, a medical device used in ureteroscopic kidney stone management procedures. BackStop was approved as a Class II device under the pre-market notification 510(k) process. It is based on Pluromed’s proprietary Rapid Transition Polymers (RTP™) that are liquid at low temperature and transition to gel at body temperature; the transition is reversible via cooling and the gel is completely dissolvable. BackStop is used in the treatment of kidney stones, a disease estimated to affect 5 million people worldwide annually.

It is Woburn, MA-based Pluromed’s first FDA approval. Pluromed’s CEO Jean-Marie Vogel said, “We are pleased to be executing the plan we presented to the Massachusetts Life Sciences Center that resulted in the Accelerator Loan, funding that has contributed to our substantial progress in a very short period of time.”

Comments»

1. Joe Martinez - 10/08/2009

Just announced! Boston Scientific, a worldwide developer and marketer of medical devices, will distribute Pluromed’s recently approved BackStop (TM) device. Read the full release here: http://www.prweb.com/releases/2009/10/prweb3011074.htm


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: